• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Small-molecule activators of RNase L with broad-spectrum antiviral activity (PNAS)

Alesh

Senior Member
Messages
191
Location
Czech Republic, EU
http://www.pnas.org/content/104/23/9585.full.pdf+html?sid=0ecbc4b5-5d0d-41f8-8bfb-1009d9a5463f


According to the authors the first two molecules (number 1 and 2) are the most effective ones.

moleculesFig6.jpg
 

Alesh

Senior Member
Messages
191
Location
Czech Republic, EU
I identified the first two molecules by their IUPAC name as:

compound 1: ethyl (5Z)-5-[(3-hydroxyphenyl)methylidene]-4-oxo-2-(phenylamino)-4,5-dihydrothiophene-3-carboxylate

compound 2: 5-(3-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one


Unfortunately, they don't seem to be approved drugs .